Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
RNPC3‐JAK2 fusion + Chr t(1;9)(p13;p22)
i
Other names:
RNPC3, RNA Binding Region (RNP1, RRM) Containing 3, SNRNP65, RBM40, U11/U12 Small Nuclear Ribonucleoprotein 65 KDa Protein, RNA-Binding Region-Containing Protein 3, RNA-Binding Motif Protein 40, U11/U12 SnRNP 65 KDa Protein, RNA-Binding Protein 40, U11/U12 SnRNP 65K, U11/U12-65K, KIAA1839, RNP, FLJ20008, IGHD5, JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3717
;
55599
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
JAK2 underexpression (5)
JAK2 overexpression (1)
JAK2 underexpression (5)
JAK2 overexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
RNPC3‐JAK2 fusion + Chr t(1;9)(p13;p22)
B Acute Lymphoblastic Leukemia
RNPC3‐JAK2 fusion + Chr t(1;9)(p13;p22)
B Acute Lymphoblastic Leukemia
ruxolitinib
Resistant: C4 – Case Studies
ruxolitinib
Resistant
:
C4
ruxolitinib
Resistant: C4 – Case Studies
ruxolitinib
Resistant
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.